Summary:
The Accrual to Clinical Trials (ACT) project goal is to create a federated network of National Clinical and Translational Science Award (CTSA) Consortium institutions to significantly increase participant accrual to the nation’s highest priority clinical trials. PHASE ONE consisted of the formation of a SHRINE network of participating institutions in order to query for aggregate patient counts across all sites in real-time. PHASE TWO, as shown in the illustration above, continues the workflow at the local site by enabling the reviewing and selection of patients locally in i2b2.
Table of Contents:
Did you know?
Users in Phase One need only the DATA_OBFSC (Obfuscated) i2b2 role for aggregated patient counts in the SHRINE. In Phase Two, users are required to have the DATA_LDS (Limited Data Set) i2b2 role in order to generate a table of patients to review
